WuXi AppTec stock at EUR 22.03 ahead of the Xetra open: CRDMO group
Published on 10/19/2026 at 07:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBusiness model and agenda
- WuXi AppTec provides contract research, development and manufacturing services for drug developers.
- The company is scheduled to report third-quarter 2026 results on October 27, 2026.
- WuXi AppTec stock trades pre-market at EUR 22.03 at 7:58 a.m. CEST at Lang & Schwarz on October 19, 2026.
WuXi AppTec provides contract research, development and manufacturing services for pharmaceutical and life sciences companies through an integrated platform, according to the company’s investor-relations site. WuXi AppTec stock trades pre-market at EUR 22.03 at 7:58 a.m. CEST at Lang & Schwarz on October 19, 2026.
Ahead of the Xetra open
The further course from the Xetra open at 9:00 a.m. CEST is shown by the continuously updated real-time quote of WuXi AppTec stock.
The group and its market
WuXi AppTec earns revenue by providing research, development and manufacturing services across the drug-development cycle, including chemistry, biology and testing, as described by the company’s investor-relations site. WuXi AppTec is scheduled to report third-quarter 2026 results on October 27, 2026, according to Simply Wall St. Market context: Market report Shanghai Composite.
